MEDIGENE AG NA O.N./ DE000A1X3W00 /
| 2024-04-19 9:08:42 PM | Chg. -0.05 | Volume | Bid9:58:00 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.91EUR | -2.30% | 20,600 Turnover: 39,792.25 |
1.87Bid Size: 900 | 1.97Ask Size: 2,100 | 47.16 mill.EUR | 0.00% | - |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1.2000 | 1.1000 | 1 | .8000 | .6000 | ||||||
| Intangible Assets | 28.5000 | 30.5000 | 31.9000 | 27.7000 | 27.4000 | ||||||
| Long-Term Investments | 3.8000 | 2.2000 | 5.3000 | 4.5000 | 6.6000 | ||||||
| Fixed Assets | 44.6000 | 45 | 40.3000 | 35.2000 | 36.8000 | ||||||
| Inventories | 2.2000 | 1.5000 | 1.7000 | 2.2000 | 2.2000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 25.1000 | 12.3000 | 4.8000 | 12.8000 | 20.1000 | ||||||
| Current Assets | 36.2000 | 20.8000 | 17.9000 | 18.1000 | 24.4000 | ||||||
| Total Assets | 80.7000 | 65.7000 | 58.2000 | 53.3000 | 61.3000 | ||||||
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.5000 | 2.5000 | 2.4000 | 1.8000 | .7000 | ||||||
| Long-term debt | .2000 | - | - | .3000 | 12.2000 | ||||||
| Liabilities to Banks | .2000 | 0.0000 | 0.0000 | 2.6000 | 15.1000 | ||||||
| Provisions | .5000 | .5000 | - | - | - | ||||||
| Liabilities | 15.8000 | 13.9000 | 17.4000 | 5.4000 | 17 | ||||||
| Share Capital | 8.5000 | 8.9000 | 9.2710 | 9.2710 | 9.2710 | ||||||
| Total Equity | 64.9000 | 51.9000 | 40.8000 | 47.9000 | 44.2000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 80.7000 | 65.7000 | 58.2000 | 53.3000 | 61.3000 | ||||||
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 33.5000 | 37.9000 | 2.2000 | 2.3000 | 3.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -31.7000 | -19.6000 | -27.6000 | -15.7000 | -16.4000 | ||||||
| Interest Income | 1.5000 | .1000 | - | .1000 | -1.2000 | ||||||
| Income Before Taxes | -33.1000 | -21.9000 | -27.2000 | -15.5000 | -14.8000 | ||||||
| Income Taxes | -2.4000 | 0.0000 | 0.0000 | -1.2000 | .1000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -30.8000 | -22 | -17.9000 | 6.3000 | -10 | ||||||
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -27.4000 | -18.9000 | -11.4000 | 6.9000 | -6.5000 | ||||||
| Cash Flow from Investing Activities | 4.3000 | .2000 | -.3000 | 1.4000 | -.3000 | ||||||
| Cash Flow from Financing | 1.7000 | 5.7000 | 4.5000 | 0.0000 | 14.1000 | ||||||
| Decrease / Increase in Cash | -21.3000 | -13 | -7.3000 | 8.3000 | 7.3000 | ||||||
| Employees | 133 | 114 | 92 | 52 | 53 | ||||||
